Flaggemelding
Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag kjøpt 240 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS 2 000 000 aksjer, noe som utgjør 5,36% av aksjene i PCI Biotech Holding ASA.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
- Xanadu Appoints Tara Deakin as Chief People Officer to Lead Next Phase of Global Growth
- GREEN FUEL FORWARD EXPANDS INDUSTRY ALLIANCE TO SUPPORT SUSTAINABLE AVIATION FUEL ADOPTION IN ASIA
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share